Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: Sepsis-associated encephalopathy (SAE) is a prevalent and severe complication in septic patients, characterized by diffuse brain dysfunction and high mortality rates. Current treatment options are limited, necessitating the exploration of novel therapeutic approaches. Echinacoside (ECH) has demonstrated neuroprotective effects in various neurodegenerative models. This study investigates the neuroprotective potential of ECH on SAE and elucidates the underlying mechanism.
Methods: A sepsis model was established using male C57BL/6 mice (8-10 weeks old) via cecum ligation and puncture (CLP). Cognitive impairment was assessed by open field test (OFT), sucrose preference test (SPT), elevated plus maze test (EPM), and Barnes maze test (BMT). Mitochondrial ultrastructure in the cortex was observed by Transmission electron microscopy. mRNA and protein expression levels were measured by RT-qPCR, Western blot, and immunohistochemical staining.
Results: ECH administration significantly alleviated cognitive impairment in septic mice, meanwhile, dysfunction of microglial mitochondria, release of reactive oxygen species, activation of cGAS/stimulator of interferon genes (STING) signaling pathway has been found reversed after the ECH treatment. Furthermore, increase the release of ROS can significantly rescued the neuroprotective effect of ECH on septic mice.
Conclusions: These findings suggest that ECH exerts its neuroprotective effects by targeting the cGAS-STING pathway, offering a promising therapeutic strategy for SAE.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejphar.2025.178092 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Metformin-Associated Lactic Acidosis (MALA): When a Common Drug Turns Catastrophic.
Cureus
August 2025
Internal Medicine, Edward Via College of Osteopathic Medicine, Auburn, USA.
Metformin, a first-line agent in the treatment of type 2 diabetes mellitus, is widely favored for its efficacy and safety profile; however, under conditions of impaired renal function, it can lead to metformin-associated lactic acidosis (MALA), a rare but life-threatening complication. The diagnosis requires careful exclusion of other causes of lactic acidosis, such as sepsis or hypoperfusion, which can mimic MALA. We present a case of an 88-year-old female with type 2 diabetes and chronic kidney disease (CKD) stage III who developed severe lactic acidosis and encephalopathy in the setting of acute kidney injury and recent infection.
View Article and Find Full Text PDFSigma-1 receptor activation by PRE-084 attenuates sepsis-associated encephalopathy by targeting microglial p38 MAPK-mediated neuroinflammation and neuronal endoplasmic reticulum stress.
Inflamm Res
September 2025
Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China.
Background: Sepsis-Associated Encephalopathy (SAE) is a severe neurological complication of sepsis, where neuroinflammation plays a critical pathogenic role, leading to cognitive dysfunction. The Sigma-1 receptor (Sigma-1R), a chaperone protein, is implicated in neuroprotection, including the crucial modulation of neuroinflammation and endoplasmic reticulum stress (ERS). This study aimed to investigate the therapeutic potential of the Sigma-1R agonist, PRE-084, in specifically targeting SAE-associated neuroinflammation and its downstream neuropathology.
View Article and Find Full Text PDFReduced phosphatidylcholine and phosphatidylethanolamine levels correlate with inflammatory activation in sepsis-associated encephalopathy.
Eur J Med Res
August 2025
Emergency Department, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Background: Sepsis-associated encephalopathy (SAE) is a severe complication of sepsis, often leading to poor neurological outcomes. Lipid molecules are increasingly recognized for their potential involvement in both sepsis and cognitive impairment. However, the relationship between lipidomic alterations and SAE remains incompletely understood.
View Article and Find Full Text PDFEchinacoside mitigates sepsis-associated encephalopathy by inhibiting STING pathway and reducing neuroinflammation.
Eur J Pharmacol
August 2025
School of Medical Instrument and Food Engineering USST, University of Shanghai for Science and Technology, Shanghai, 200093, China; Department of Anesthesiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, 200030, China. Electronic address: wu_jingxiang@sjtu
Purpose: Sepsis-associated encephalopathy (SAE) is a prevalent and severe complication in septic patients, characterized by diffuse brain dysfunction and high mortality rates. Current treatment options are limited, necessitating the exploration of novel therapeutic approaches. Echinacoside (ECH) has demonstrated neuroprotective effects in various neurodegenerative models.
View Article and Find Full Text PDFAcute liver failure etiology, clinical manifestation and outcomes in adults: Experience of tertiary care hospital in Karachi.
World J Crit Care Med
September 2025
Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.
Background: Many causal factors influence acute liver failure (ALF), including the primary underlying cause, age, and socioeconomic conditions. ALF outcomes depend on etiology, coagulopathy, bilirubin, age, and understanding of hepatic encephalopathy (HE), and help us predict coma and death.
Aim: To evaluate the association between etiologies, clinical manifestations, and outcomes of adults admitted with ALF.